Research Options: Select below IPO Calendar	Week of Expected Pricing Withdrawn Company Name Ambrx Inc Proposed Ticker AMBX CUSIP 02337M101 Business Description A clinical stage biotechnology company focused on discovering and developing first-in-class and best-in-class optimized protein therapeutics known as bio-conjugates. Lead Underwriter Stifel Nicolaus & Company, Incorporated,Wells Fargo Securities, LLC. Co-Managers Canaccord Genuity Inc,Needham & Company, LLC,Roth Capital Partners, Inc. Initial Shares 54,00,000 Revised Initial Shares N/A Initial Price $12.00-$14.00 Revised Price N/A Final Price N/A Final Ticker N/A
	© 2024 ICE Data Services. All rights reserved.